WWD-30481-32470
4 vaccinations
6 coded responses
41 check-ins
6 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 452 / OH
- Registered
- 2021-01-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
3YB-30274-40435
Child or adolescent in my care · Male · 2022-06-27
ZQH-87255-78194
Child or adolescent in my care · Female · 2022-06-27
2YZ-45216-47515
Child or adolescent in my care · Male · 2023-03-22
Timeline
-
2021-01-27
Registered in v-safe
-
2021-01-27
Dose 1 — Moderna
- 2021-01-27
-
2021-01-28
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-01-29
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-10
- 2021-02-17
-
2021-02-22
Dose 2 — Moderna
- 2021-02-22
-
2021-02-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-02-24
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Diarrhea, Abdominal painAdult check-in
- 2021-02-25
-
2021-02-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fatigue or tiredness, DiarrheaAdult check-in
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-08
- 2021-03-15
- 2021-03-22
- 2021-03-29
-
2021-04-05
Survey response — day 42, dose 2MedDRA: Endometriosis — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Endometritis during postpartum periodMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-05
Report sent to call center — day 42, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-24
- 2021-06-16
- 2021-08-23
-
2021-10-27
Dose 3 — Pfizer-BioNTech
-
2021-10-28
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-10-29
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessFree text: Notable Axillary Lymph node swellingMedDRA releases: 2024-11 · check-in free text available
-
2021-10-30
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: PainFree text: Axillary lymph node tenderness, swellingMedDRA releases: 2024-11 · check-in free text available
-
2021-10-31
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: GoodFree text: Axillary lymph node swelling and tendernessMedDRA releases: 2024-11 · check-in free text available
- 2021-11-01
- 2021-11-02
- 2021-11-05
- 2021-11-10
- 2021-11-17
- 2021-11-24
- 2021-12-01
-
2021-12-08
Survey response — day 42, dose 3MedDRA: Migraine — Feeling: Poor · Be unable to do your normal daily activitiesFree text: MigraineMedDRA releases: 2024-11 · check-in free text available
- 2022-01-26
-
2022-04-27
Survey response — 6 months, dose 3MedDRA: Pre-existing disease, Pregnancy — Feeling: GoodFree text: Pregnancy Continued hypothyroidism (treated)MedDRA releases: 2024-11 · check-in free text available
- 2022-10-27
-
2022-10-28
Dose 4 — Pfizer-BioNTech
- 2023-04-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-27 | Moderna | |
| 2 | 2021-02-22 | Moderna | |
| 3 | 2021-10-27 | Pfizer-BioNTech | No |
| 4 | 2022-10-28 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-05 | Unsuccessful |
Free text
Release 6 — day 42, dose 2
Symptoms: Endometritis during postpartum period
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Notable Axillary Lymph node swelling
Systemic reaction (other): Axillary lymph node tenderness, swelling
Systemic reaction (other): Axillary lymph node swelling and tenderness
Release 10 — day 42, dose 3
Symptoms: Migraine
Release 11 — 6 months, dose 3
Symptoms: Pregnancy Continued hypothyroidism (treated)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Endometriosis | ✓ | ✓ | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SRO | Lymph node pain | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release